SKLB-03220, CAS [[2852050-29-2]]

Produktübersicht

• Artikelname: SKLB-03220, CAS [[2852050-29-2]]
• Artikelnummer: TGM-T207811
• Hersteller Artikelnummer: T207811
• Alternativnummer: TGM-T207811-1MG,TGM-T207811-5MG,TGM-T207811-10MG,TGM-T207811-25MG,TGM-T207811-50MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: Sklb-03220 , SKLB03220

Produktbeschreibung

SKLB-03220 is an orally bioavailable covalent inhibitor targeting the histone methyltransferase EZH2, an established oncology drug target involved in epigenetic regulation. SKLB-03220 is structurally based on the clinically approved EZH2 inhibitor tazemetostat and demonstrates the ability to abolish epigenetic H3K27me3 marks, thereby altering chromatin state and transcriptional activity. SKLB-03220 represents a potent small-molecule tool for cancer epigenetics research.

Produkteigenschaften

• Molekulargewicht: 556.71
• Reinheit: 97.02%
• CAS Nummer: [2852050-29-2]
• Formel: C33H40N4O4
• Target-Kategorie: Histone Methyltransferase

Bilder

T207811